BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34526778)

  • 1. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway.
    Jia J; Wang J; Yin M; Liu Y
    Onco Targets Ther; 2019; 12():5437-5448. PubMed ID: 31360068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4961-4962. PubMed ID: 34675537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4935-4936. PubMed ID: 34611412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction].
    Onco Targets Ther; 2021; 14():4963-4964. PubMed ID: 34629879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2023; 16():1023-1024. PubMed ID: 38090112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction].
    Onco Targets Ther; 2021; 14():4897-4898. PubMed ID: 34594110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin Potentiates the Potent Antitumor Activity of ACNU Against Glioblastoma by Suppressing the PI3K/AKT and NF-κB/COX-2 Signaling Pathways [Retraction].
    Onco Targets Ther; 2022; 15():1479-1480. PubMed ID: 36483451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-559 Plays an Inhibitory Role in the Malignant Progression of Glioblastoma Cells by Directly Targeting Metadherin [Retraction].
    Onco Targets Ther; 2021; 14():4899-4900. PubMed ID: 34594111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis [Retraction].
    Onco Targets Ther; 2020; 13():12721. PubMed ID: 33328742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-939 Directly Targets
    Onco Targets Ther; 2021; 14():5001-5002. PubMed ID: 34675543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():1859. PubMed ID: 33732003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Long Non-Coding RNA-HCG18 Inhibits the Tumorigenesis of Gastric Cancer Through Blocking PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2020; 13():12195. PubMed ID: 33273823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Immature Colon Carcinoma Transcript-1 Inhibits Proliferation of Glioblastoma Multiforme Cells through Gap 2/Mitotic Phase Arrest [Retraction].
    Onco Targets Ther; 2023; 16():479-480. PubMed ID: 37396309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction].
    Onco Targets Ther; 2021; 14():4991-4992. PubMed ID: 34675539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA1 Gene Silencing Inhibits Invasion, Proliferation and Migration of Cholangiocarcinoma Stem Cells via Disrupting the PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2021; 14():1005. PubMed ID: 33603406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kanglaite Reverses Multidrug Resistance of HCC by Inducing Apoptosis and Cell Cycle Arrest via PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2024; 17():99-100. PubMed ID: 38371878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Fibrous Sheath Interacting Protein 1 Expression Reduces Bladder Urothelial Carcinoma Cell Proliferation and Induces Apoptosis via Inhibition of the PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2022; 15():85-86. PubMed ID: 35087278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.